AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 52 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $258 | -69.1% | 572 | -80.2% | 0.00% | – |
| Q1 2023 | $836 | -41.6% | 2,882 | -9.4% | 0.00% | – |
| Q4 2022 | $1,432 | -28.4% | 3,182 | +2.6% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 3,100 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -71.4% | 3,100 | +3.3% | 0.00% | – |
| Q1 2022 | $7,000 | -72.0% | 3,000 | -43.4% | 0.00% | – |
| Q4 2021 | $25,000 | +1150.0% | 5,300 | +1666.7% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 300 | +50.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 200 | +100.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |